Detailed answers about EMINENT CARDIOVASCULAR GROUP LIMITED, including incorporation, status, business activity, and accounts information.
When was EMINENT CARDIOVASCULAR GROUP LIMITED founded?
EMINENT CARDIOVASCULAR GROUP LIMITED was officially incorporated on 22 December 2025 and is registered under company number 16927678. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is EMINENT CARDIOVASCULAR GROUP LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of EMINENT CARDIOVASCULAR GROUP LIMITED?
EMINENT CARDIOVASCULAR GROUP LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does EMINENT CARDIOVASCULAR GROUP LIMITED do?
EMINENT CARDIOVASCULAR GROUP LIMITED operates in the following sectors: 62020 - Information technology consultancy activities, 86220 - Specialists medical practice activities. These SIC codes provide insight into the company's business activities and industry focus.
What is EMINENT CARDIOVASCULAR GROUP LIMITED's registered address?
The registered office address of EMINENT CARDIOVASCULAR GROUP LIMITED is 21 BLITHFIELD WAY, STOKE-ON-TRENT, ENGLAND, ST6 8GS. This is the official address filed with Companies House for legal and statutory correspondence.
Is EMINENT CARDIOVASCULAR GROUP LIMITED financially stable?
Financial accounts for EMINENT CARDIOVASCULAR GROUP LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.